2023-11-14T12:23:27-06:00 2022-12-31 390859910 BAKER TILLY US LLP 1 HIGHWOOD DRIVE TEWKSBURY MA 01876 990 2022-01-01 222473000 INTERNATIONAL SOCIETY FOR INFECTIOUS DISEASES INC INTE 6179255272 867 BOYLSTON STREET 5TH FLOOR 198 BOSTON MA 02116 LINDA MACKINNON CEO 6179255272 2023-11-13 1 LINDA MACKINNON 999009999 0 MATTHEW KALIL CPA MBA P01517069 9785575300 2023-11-09 2 AAL1 IAL1 2022 2023-04-26 12:10:37Z X LINDA MACKINNON 867 BOYLSTON STREET 5TH FLOOR 1985 BOSTON MA 02116 4604465 0 X WWW.ISID.ORG X 1983 MA EDUCATION PERTAINING TO INFECTIOUS DISEASES. 9 9 12 0 0 0 1294679 656607 0 1722381 341429 -27113 559817 509462 2195925 2861337 16000 7500 0 0 1180149 1654990 0 0 89604 2080879 2438805 3277028 4101295 -1081103 -1239958 4197503 2622557 1049167 860696 3148336 1761861 X THE MISSION OF INTERNATIONAL SOCIETY FOR INFECTIOUS DISEASES IS TO SUPPORT HEALTH PROFESSIONALS, NON-GOVERNMENT ORGANIZATIONS, AND GOVERNMENTS AROUND THE WORLD IN THEIR WORK TO PREVENT, INVESTIGATE AND MANAGE INFECTIOUS DISEASE OUTBREAKS WHEN THEY OCCUR, PARTICULARLY IN COUNTRIES THAT HAVE LIMITED RESOURCES AND WHICH DISPROPORTIONATELY BEAR THE BURDEN OF INFECTIOUS DISEASES. 0 0 2893208 7500 2231843 TO INCREASE KNOWLEDGE BASE OF INFECTIOUS DISEASE THROUGH RESEARCH AND TRAINING AND TO ENHANCE PROFESSIONAL DEVELOPMENT OF INDIVIDUALS IN THIS DISCIPLINE. SCIENTIFIC EXCHANGE FELLOWSHIP PROGRAM IS INTENDED TO ALLOW SCIENTISTS FROM DEVELOPING COUNTRIES TO UPDATE THEIR KNOWLEDGE OF NEW TECHNIQUES AND SKILLS IN THE FIELD OF INFECTIOUS DISEASES. THE SMALL GRANTS PROGRAM IS INTENDED TO FOSTER DEVELOPMENT OF YOUNG INFECTIOUS DISEASE PROFESSIONALS IN THE DEVELOPING WORLD. 2893208 1 1 0 0 0 0 0 0 0 0 1 0 0 0 0 1 1 0 0 1 0 0 1 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 32 0 1 12 1 0 0 0 0 0 0 0 0 0 0 0 0 X 9 9 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 0 MA X THE ORGANIZATION 6179255272 867 BOYLSTON STREET 5TH FLOOR 1985 BOSTON MA 02116 JAFFAR AL-TAWFIQ BOARD MEMBER (SINCE 1/1/2022) 1.00 X 0 0 0 GONZALO BEARMAN BOARD MEMBER (SINCE 1/1/2022) 1.00 X 0 0 0 HELENA MALTEZOU BOARD MEMBER (SINCE 1/1/2022) 1.00 X 0 0 0 CONNIE WALYARO BOARD MEMBER (SINCE 1/1/2022) 1.00 X 0 0 0 ROBERT HEYDERMAN BOARD MEMBER 1.00 X 0 0 0 NEELIKA MALAVIGE BOARD MEMBER 1.00 X 0 0 0 ALLISON HOLMES PAST PRESIDENT 1.00 X 0 0 0 PAUL TAMBYAH PRESIDENT 1.00 X X 0 0 0 SALLY ROBERTS TREASURER & PRESIDENT ELECT 5.00 X X 0 0 0 LINDA MACKINNON CEO 40.00 X 208331 0 15212 ANDREW DALECKI CFO (UNTIL 11/30/2022) 40.00 X 246643 0 13232 CATHERINE CROWLEY DIRECTOR OF BUSINESS DEVELOPMENT 40.00 X 118517 0 8661 JULIA MAXWELL DIRECTOR OF DISEASE SURVEILLANCE 40.00 X 102748 0 7310 676239 0 44415 4 0 1 0 BOSTON CHILDREN'S HOSPITAL 300 LONGWOOD AVENUE BOSTON MA 02115 PROMED RELATED RESEARCH COLLABORATION 226250 IMPERIAL COLLEGE LONDON LEVEL 3 SHERFIELD BLDG SOUTH KENSI LONDON SW AZ ENGLAND UK PROMED RELATED RESEARCH COLLABORATION 107228 2 656607 656607 EVENT REGISTRATION & SPONSORSHIPS 900099 1661402 1661402 CONTRACT REVENUE 900099 60979 60979 1722381 21618 21618 509462 509462 1694397 1743128 -48731 -48731 -48731 2861337 2231843 0 -27113 X 7500 7500 483418 115405 345659 22354 977633 725495 227987 24151 37124 25816 11041 267 55964 37959 15951 2054 100851 58675 39009 3167 123602 123602 35501 35501 8624 8624 1215787 1153320 29961 32506 82215 62285 19930 127371 9705 117561 105 76892 52706 19186 5000 11065 11065 304489 241687 62802 29665 29665 12390 12390 EVENT COSTS 404827 404827 TRAINING 6377 -2172 8549 4101295 2893208 1118483 89604 210000 548255 992527 746145 725916 936667 5222 9080 724568 342158 391445 382410 1872393 0 4197503 2622557 531833 354608 517334 506088 1049167 860696 X 1589510 932706 1558826 829155 3148336 1761861 4197503 2622557 X -1239958 -129265 -16000 -1252 X X 0 1 X 1 0 X 1934428 2819213 2294122 1294679 656607 8999049 1934428 2819213 2294122 1294679 656607 8999049 2701492 6297557 240284 235693 710565 632592 531080 2350214 11349263 1722381 0.55490 0.56890 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 611835 258290 353545 78584 62122 16462 34149 21746 12403 382410 X 2722196 -129265 -1252 -130517 2852713 8624 8624 2861337 4092671 0 4092671 8624 8624 4101295 PART X, LINE 2: THE ORGANIZATION IS A NONPROFIT ORGANIZATION AS DESCRIBED IN SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE AND IS EXEMPT FROM FEDERAL AND STATE INCOME TAXES ON TRADE OR BUSINESS PROFITS GENERATED BY ACTIVITIES RELATED TO THE ORGANIZATION'S EXEMPT FUNCTION. THE ORGANIZATION MAY BE SUBJECT TO FEDERAL AND STATE INCOME TAXES FOR PROFITS GENERATED FROM TRADE OR BUSINESS ACTIVITIES UNRELATED TO THE ORGANIZATION'S EXEMPT FUNCTION. AS OF DECEMBER 31, 2022, MANAGEMENT BELIEVES THAT THE ORGANIZATION HAS NOT GENERATED ANY UNRELATED BUSINESS TAXABLE INCOME. THE ORGANIZATION ASSESSES THE RECORDING OF UNCERTAIN TAX POSITIONS BY EVALUATING THE MINIMUM RECOGNITION THRESHOLD AND MEASUREMENT REQUIREMENTS A TAX POSITION MUST MEET BEFORE BEING RECOGNIZED AS A BENEFIT IN THE FINANCIAL STATEMENTS. THE ORGANIZATION'S POLICY IS TO RECOGNIZE INTEREST AND PENALTIES ACCRUED ON ANY UNCERTAIN TAX POSITIONS AS A COMPONENT OF INCOME TAX EXPENSE, IF ANY, IN ITS STATEMENTS OF ACTIVITIES. THE ORGANIZATION HAS NOT RECOGNIZED ANY LIABILITIES FOR UNCERTAIN TAX POSITIONS OR UNRECOGNIZED BENEFITS AS OF DECEMBER 31, 2022. THE ORGANIZATION DOES NOT EXPECT ANY MATERIAL CHANGE IN UNCERTAIN TAX BENEFITS WITHIN THE NEXT 12 MONTHS. PART XI, LINE 2D - OTHER ADJUSTMENTS: LOSS ON FOREIGN CURRENCY EXCHANGE -1,252. 1 0 0 0 0 0 0 0 0 0 RESEARCH FELLOWSHIP SUB-SAHARAN AFRICA 1 7500 WIRE TRANSFER 0 0 0 0 0 0 0 PART I, LINE 2: A WRITTEN REPORT OF THE PROJECT IS REQUIRED FROM GRANT RECIPIENTS. THE REPORT MUST BE SENT TO INTERNATIONAL SOCIETY FOR INFECTIOUS DISEASES AND RECIPIENTS ARE ENCOURAGED TO PRESENT THEIR FINDINGS AT SCIENTIFIC MEETINGS OR IN PEER REVIEWED PUBLICATIONS. PART III ACCOUNTING METHOD: X X 0 0 0 0 0 0 0 0 0 ANDREW DALECKI CFO (UNTIL 11/30/2022) 246643 0 0 0 0 0 3217 0 10015 0 259875 0 0 0 LINDA MACKINNON CEO 189791 0 18540 0 0 0 14583 0 629 0 223543 0 0 0 FORM 990, PART VI, SECTION B, LINE 11B THE 990 IS PREPARED BY AN INDEPENDENT ACCOUNTING FIRM AND THEN REVIEWED BY THE DIRECTOR OF FINANCE AND THE EXECUTIVE DIRECTOR. THE 990 IS THEN MADE AVAILABLE TO THE BOARD OF DIRECTORS PRIOR TO ITS FILING. FORM 990, PART VI, SECTION B, LINE 12C BOARD MEMBERS ARE REQUIRED TO COMPLETE A CONFLICT OF INTEREST STATEMENT THAT DISCLOSES ANY CONFLICT OF INTERESTS THEY MAY HAVE. ALL CONFLICTS ARE TO BE DECLARED AT THE BEGINNING OF EACH COMMITTEE MEETING AND DISCUSSED ACCORDINGLY. FORM 990, PART VI, SECTION B, LINE 15 SALARY LEVELS ARE BASED ON EVALUATION OF FACTORS INCLUDING, BUT NOT LIMITED TO; THE AMOUNT AND SCOPE OF KNOWLEDGE, TRAINING AND/OR SPECIALIZED SKILLS REQUIRED; SCOPE AND RANGE OF RESPONSIBILITIES OF THE POSITION; THE ORGANIZATIONAL AUTHORITY; LEVEL OF SUPERVISION EXERCISED; THE SCOPE AND TYPE OF INTERACTION WITH OTHER EMPLOYEES, MEMBERS, BOARD AND COMMITTEE MEMBERS, PEERS IN OTHER ORGANIZATIONS, VENDORS, PROFESSIONAL PARTNERS; AND BASED ON COMPARATIVE INDUSTRY BENCHMARKS. SALARY LEVELS ARE APPROVED BY THE EXECUTIVE COMMITTEE. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC UPON REQUEST. FORM 990, PART IX, LINE 11G OTHER PROFESSIONAL FEES: PROGRAM SERVICE EXPENSES 1,153,320. MANAGEMENT AND GENERAL EXPENSES 29,961. FUNDRAISING EXPENSES 32,506. TOTAL EXPENSES 1,215,787. FORM 990, PART XI, LINE 9: LOSS ON FOREIGN CURRENCY EXCHANGE -1,252. FORM 990, PART XII, LINE 2C: THE ORGANIZATION HAS A COMMITTEE THAT ASSUMES RESPONSIBILITY FOR OVERSIGHT FOR THE AUDIT OF ITS FINANCIAL STATEMENTS AND SELECTION OF AN INDEPENDENT ACCOUNTANT. THIS PROCESS HAS NOT CHANGED DURING THE YEAR.